What is 4D Biomaterials?
4D Biomaterials is a United Kingdom-based company founded in 2020, specializing in the development of advanced 3D printing resin-inks designed for targeted and controlled regeneration of human tissue. The company's proprietary technology offers a unique set of properties crucial for tissue engineering applications, positioning it at the forefront of regenerative medicine innovation. The recent strategic investment signals strong market confidence in its technological capabilities and its potential to address critical unmet needs in healthcare.
How much funding has 4D Biomaterials raised?
4D Biomaterials has raised a total of $2.2M across 1 funding round:
Unspecified
$2.2M
Unspecified (2021): $2.2M with participation from DSW Ventures, MEIF, and SFC Capital Partners
Key Investors in 4D Biomaterials
DSW Ventures
DSW Ventures is an early-stage venture capital firm based in the UK, focusing on innovative businesses led by talented founders. The firm invests between £100,000 and £3 million in regional start-ups, primarily in the software, spin-outs, and consumer sectors.
MEIF
MEIF is a significant backer in the UK's regional start-up ecosystem, providing crucial investment to fuel growth and innovation across various sectors.
SFC Capital Partners
SFC Capital Partners Ltd specializes in fund management and corporate finance services for professional investors, focusing on investments in private companies, particularly through EIS and SEIS structures.
What's next for 4D Biomaterials?
With the recent injection of capital, 4D Biomaterials is expected to scale its operations, further refine its 3D printing resin-ink technology, and expand its research and development efforts. The enterprise-level funding suggests a focus on commercialization and market expansion, potentially targeting strategic partnerships within the medical device and pharmaceutical industries. This strategic backing will likely enable the company to move closer to clinical applications and widespread adoption of its tissue regeneration solutions.
See full 4D Biomaterials company page
